Barbara Blouw

1.3k total citations
34 papers, 1.1k citations indexed

About

Barbara Blouw is a scholar working on Oncology, Molecular Biology and Cell Biology. According to data from OpenAlex, Barbara Blouw has authored 34 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 13 papers in Molecular Biology and 13 papers in Cell Biology. Recurrent topics in Barbara Blouw's work include Proteoglycans and glycosaminoglycans research (11 papers), Brain Metastases and Treatment (9 papers) and Cancer, Hypoxia, and Metabolism (7 papers). Barbara Blouw is often cited by papers focused on Proteoglycans and glycosaminoglycans research (11 papers), Brain Metastases and Treatment (9 papers) and Cancer, Hypoxia, and Metabolism (7 papers). Barbara Blouw collaborates with scholars based in United States, Norway and Italy. Barbara Blouw's co-authors include Randall S. Johnson, Gabriele Bergers, Tarık Tihan, Hans-Peter Gerber, Napoleone Ferrara, Sara A. Courtneidge, Thomas Soucek, David Schubert, Begoña Díaz and Ian Pass and has published in prestigious journals such as Journal of Neuroscience, PLoS ONE and Cancer Cell.

In The Last Decade

Barbara Blouw

31 papers receiving 1.1k citations

Peers

Barbara Blouw
Chenran Wang United States
Jean Kloss United States
Alexandre Chlenski United States
Carolina L. Bigarella United States
Ping Guo China
Christine Tan United States
Jinxiang Dai United States
Chenran Wang United States
Barbara Blouw
Citations per year, relative to Barbara Blouw Barbara Blouw (= 1×) peers Chenran Wang

Countries citing papers authored by Barbara Blouw

Since Specialization
Citations

This map shows the geographic impact of Barbara Blouw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Blouw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Blouw more than expected).

Fields of papers citing papers by Barbara Blouw

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Blouw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Blouw. The network helps show where Barbara Blouw may publish in the future.

Co-authorship network of co-authors of Barbara Blouw

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Blouw. A scholar is included among the top collaborators of Barbara Blouw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Blouw. Barbara Blouw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blouw, Barbara, D. A. D. Montgomery, Melissa M. Moore, et al.. (2025). Longitudinal CSF Tumor Cell Enumeration and Mutational Analysis as a Driver for Leptomeningeal Disease Management. Cancers. 17(5). 825–825.
3.
Blouw, Barbara, Tony J. Pircher, Julie Ann Mayer, et al.. (2024). A Microfluidic, Multi-Antibody Cell Capture Method to Evaluate Tumor Cells in Cerebrospinal Fluid in Patients With Suspected Leptomeningeal Metastases. Archives of Pathology & Laboratory Medicine. 149(3). 242–252. 1 indexed citations
5.
Barbour, Andrew B., Barbara Blouw, Lynne P. Taylor, et al.. (2024). Prognostic value of cerebrospinal fluid tumor cell count in leptomeningeal disease from solid tumors. Journal of Neuro-Oncology. 167(3). 509–514. 6 indexed citations
6.
Li, Jin, Jessica K.R. Boult, J. D. Sullivan, et al.. (2023). Investigating the contribution of hyaluronan to the breast tumour microenvironment using multiparametric MRI and MR elastography. Molecular Oncology. 17(6). 1076–1092. 4 indexed citations
7.
Puri, Sonam, Rachna Malani, A. Chalmers, et al.. (2023). Keeping a track on leptomeningeal disease in non–small cell lung cancer: A single-institution experience with CNSideTM. Neuro-Oncology Advances. 6(1). vdad150–vdad150. 3 indexed citations
8.
Morosi, Lavinia, Paolo Ubezio, Ilaria Fuso Nerini, et al.. (2021). PEGylated recombinant human hyaluronidase (PEGPH20) pre-treatment improves intra-tumour distribution and efficacy of paclitaxel in preclinical models. Journal of Experimental & Clinical Cancer Research. 40(1). 286–286. 47 indexed citations
10.
Blouw, Barbara, et al.. (2019). Remodeling the Tumor Microenvironment Sensitizes Breast Tumors to Anti-Programmed Death-Ligand 1 Immunotherapy. Cancer Research. 79(16). 4149–4159. 53 indexed citations
11.
Blair, Alex B., Victoria M. Kim, Stephen Muth, et al.. (2019). Dissecting the Stromal Signaling and Regulation of Myeloid Cells and Memory Effector T Cells in Pancreatic Cancer. Clinical Cancer Research. 25(17). 5351–5363. 64 indexed citations
12.
Li, Xiaoming, H. Michael Shepard, Chun‐Mei Zhao, et al.. (2018). Parallel Accumulation of Tumor Hyaluronan, Collagen, and Other Drivers of Tumor Progression. Clinical Cancer Research. 24(19). 4798–4807. 69 indexed citations
13.
Cao, Jianbo, Stephen Pickup, Cynthia Clendenin, et al.. (2018). Dynamic Contrast-enhanced MRI Detects Responses to Stroma-directed Therapy in Mouse Models of Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research. 25(7). 2314–2322. 23 indexed citations
14.
Scholz, Wolfgang, Paul Resnick, Xiaoming Li, et al.. (2018). Abstract 3036: PEGylated hyaluronidase increases tumor uptake of 89Zr-DFO-HuMab-5B1 (MVT-2163) in a CA19-9 positive hyaluronan-accumulating pancreatic cancer model. Cancer Research. 78(13_Supplement). 3036–3036. 1 indexed citations
15.
Wang, Lin, Sanna Rosengren, Lei Huang, et al.. (2016). Abstract 1472: Enzymatic depletion of adenosine by pegylated, engineered adenosine deaminase 2 (PEG-ADA2): A novel immunotherapeutic approach to treat solid tumors. Cancer Research. 76(14_Supplement). 1472–1472. 1 indexed citations
16.
Blouw, Barbara, Shinji Iizuka, Xiayu Huang, et al.. (2015). The Invadopodia Scaffold Protein Tks5 Is Required for the Growth of Human Breast Cancer Cells In Vitro and In Vivo. PLoS ONE. 10(3). e0121003–e0121003. 50 indexed citations
17.
Schubert, David, Thomas Soucek, & Barbara Blouw. (2009). The induction of HIF‐1 reduces astrocyte activation by amyloid beta peptide. European Journal of Neuroscience. 29(7). 1323–1334. 74 indexed citations
19.
Cui, Jiankun, John R. Scheel, Julie A. Ellison, et al.. (2005). Brain-Specific Knock-Out of Hypoxia-Inducible Factor-1α Reduces Rather Than Increases Hypoxic-Ischemic Damage. Journal of Neuroscience. 25(16). 4099–4107. 218 indexed citations
20.
Blouw, Barbara, Tarık Tihan, Napoleone Ferrara, et al.. (2003). The hypoxic response of tumors is dependent on their microenvironment. Cancer Cell. 4(2). 133–146. 312 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026